Share this article
SAN FRANCISCO, Feb. 16, 2021 /PRNewswire/ The global specialty medical chairs market size is expected
to reach USD 6.05 billion by 2028 registering a CAGR of 7.5%, according to a new report by Grand View Research, Inc. Increasing geriatric population is one of the major factors boosting the product adoption. As per the WHO, it is estimated that from 2025 to 2050, the older population is expected to almost double to 1.6 billion globally. According to The World Bank, the population in the Asia Pacific region is aging rapidly.
Key suggestions from the report:
The rehabilitation product segment held the dominant share of over 40% in 2020 owing to rise in the geriatric population
Share this article
SALT LAKE CITY, Feb. 16, 2021 /PRNewswire/ AMD Lasers, Inc. (AMD) begins shipment of the
world s first revolutionary handheld laser dental curing light, branded as Monet™ laser curing light, for faster and reliable dental curing.
Detailed features and virtual demos for Monet laser curing light can be found at www.amdlasers.com or call +1-866-999-2635.
AMD LASERS STARTS TO SHIP WORLD FIRST HANDHELD REVOLUTIONARY LASER CURING LIGHT – MONET LASER CURING LIGHT.
Light curing is an essential procedure in daily dental practices. LED curing light has been widely adopted into dental practices since its introduction in 2001. However, the LED curing light has certain limitations including an uncollimated light beam, light intensity decreasing dramatically from the emitting orifice, inefficient curing, etc.
Share this article
Share this article
LITTLE ROCK, Ark., Feb. 16, 2021 /PRNewswire/ DataPath, Inc., a leading developer of technology solutions for employee benefits administration, has published a whitepaper titled, COVID-19 and COBRA Continuation Insurance: Where Do We Stand? The paper takes a deeper look at the effect of the COVID-19 healthcare crisis on the economy – specifically, its impact on the COBRA insurance market – and how an upcoming deadline could wreak havoc for administrators.
In March 2020, the Federal response to the COVID healthcare crisis included a one year Outbreak Period, defined by a joint final notice issued by the Internal Revenue Service and Department of Labor as beginning March 1, 2020 and ending February 28, 2021. With the end looming, third party administrators, employers, and insurance carriers could face some serious issues regarding notices to beneficiaries, COBRA elections, and premium payments, all of which were temporarily suspended
Unexpected Findings on Weight Loss and Breast Cancer from International Study in JNCCN
New research found that weight loss after diagnosis was associated with worse outcomes for HER2-positive early breast cancer patients
News provided by
Share this article
PLYMOUTH MEETING, Pa., Feb. 16, 2021 /PRNewswire/ New research in the February 2021 issue of
JNCCN Journal of the National Comprehensive Cancer Network examined body mass index (BMI) data for people with HER2-positive early breast cancer, and found a 5% weight loss in patients over two years in was associated with worse outcomes. Weight gain over the same time period did not affect survival rates.
Share this article
Share this article
SAN DIEGO, Feb. 16, 2021 /PRNewswire/ Prometheus Biosciences, Inc. ( Prometheus ), a biotechnology company pioneering a precision medicine approach for the discovery, development, and commercialization of novel therapeutic and companion diagnostic products for the treatment of inflammatory bowel disease (IBD), today announced the appointments of Judith L. Swain, MD and Helen C. Adams to its board of directors. Ms. Adams will assume the position of Chair of the Audit Committee. We re thrilled to have Judith and Helen join our Board of Directors, who bring significant clinical medicine and financial expertise that will be important as we advance our pipeline to people living with IBD, said Mark McKenna, President and CEO of Prometheus. Judith is a distinguished physician scientist and veteran scientific advisory board member with an international perspective on drug development. Helen is an outstanding financial professional and exper